CPIX : Summary for Cumberland Pharmaceuticals Inc. - Yahoo Finance

U.S. Markets close in 2 hrs 8 mins

Cumberland Pharmaceuticals Inc. (CPIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.88-0.11 (-1.84%)
As of 4:00PM EDT. Market open.
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close5.99
Bid6.02 x 100
Ask6.08 x 100
Day's Range5.87 - 6.10
52 Week Range4.27 - 7.48
Avg. Volume23,232
Market Cap94.16M
PE Ratio (TTM)-98.00
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswireyesterday

    New Kristalose® Growth Driver Established Through Co-Promotion Agreement

    NASHVILLE, Tenn., April 26, 2017 /PRNewswire/ -- Cumberland Pharmaceuticals (CPIX), a U.S. specialty pharmaceutical company and Poly Pharmaceuticals Inc., a privately-held U.S. specialty pharmaceutical company, have entered into a co-promotion partnership for Kristalose® within the United States. Poly's sales force will more than double the number of nationwide physicians called upon in support of the product.

  • PR Newswirelast month

    Caldolor® Demonstrates Significant Post Surgical Pain Reduction and Decrease in Opioid Use

    NASHVILLE, Tenn., March 27, 2017 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (CPIX) today announced the publication of a trial providing evidence that using Caldolor in multimodal pain control strategies improves postoperative pain control and reduces opioid use in patients undergoing transsphenoidal surgery. The trial was conducted at the Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center in Phoenix, Arizona, and was published in the Journal of Neurosurgery, March 2017. "The United States is in the midst of an epidemic of excessive opioid use, misuse, and abuse to control chronic pain," said AJ Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals.

  • Accesswirelast month

    INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland Pharmaceuticals Inc.

    NEW YORK, NY / ACCESSWIRE / March 22, 2017 / Levi & Korsinsky announces it has commenced an investigation Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) concerning possible breaches of fiduciary duty. ...